Therapeutic Potential and Predictive Pharmaceutical Modeling of Stilbenes in Cannabis sativa

Pharmaceutics. 2023 Jul 12;15(7):1941. doi: 10.3390/pharmaceutics15071941.

Abstract

Cannabis sativa is a plant used for recreational and therapeutic purposes; however, many of the secondary metabolites in the plant have not been thoroughly investigated. Stilbenes are a class of compounds with demonstrated anti-inflammatory and antioxidant properties and are present in cannabis. Many stilbenes present in cannabis have been investigated for their therapeutic effects. Fourteen stilbenes have been identified to be present in cannabis, all of which are structurally dihydrostilbenoids, with half possessing a prenylated moiety. The stilbenes summarized in this analysis show varying degrees of therapeutic benefits ranging from anti-inflammatory, antiviral, and anti-cancer to antioxidant effects. Many of the identified stilbenes have been researched to a limited extent for potential health benefits. In addition, predictive in silico modeling was performed on the fourteen identified cannabis-derived stilbenes. This modeling provides prospective activity, pharmacokinetic, metabolism, and permeability data, setting the groundwork for further investigation into these poorly characterized compounds.

Keywords: anti-cancer; anti-inflammatory; bibenzyl; cannabis; in silico; stilbene.

Publication types

  • Review

Grants and funding

This work was supported by a Mitacs research grant (Mitacs MI MA IT34436 RES0061921) from Canurta to Applied Pharmaceutical Innovation and the Faculty of Pharmacy and Pharmaceutical Sciences to M.R.D., R.L., and N.M.D. The funder had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. C.O. and A.GG. are supported as Mitacs interns, and C.O. is supported by an NSERC master scholarship.